Michael J. LaBarre Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael J. LaBarre.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael J. LaBarre. Michael J. LaBarre is SVP, Chief Technical Officer in HALOZYME THERAPEUTICS, INC. ($GYHT) and VP, Product Development in HALOZYME THERAPEUTICS INC ($GYHT).
Latest Insider Trading Transactions of Michael J. LaBarre
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 03 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 11.29 | 11,311 | 127,701 | 0 | |
| May 03 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 11.29 | 11,311 | 127,701 | 134,111 | 122.8 K to 134.1 K (+9.21 %) |
| Apr 01 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 11.29 | 28,689 | 323,899 | 11,311 | |
| Apr 01 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 42.79 | 18,994 | 812,829 | 122,800 | 141.8 K to 122.8 K (-13.40 %) |
| Apr 01 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 42.11 | 9,695 | 408,208 | 141,794 | 151.5 K to 141.8 K (-6.40 %) |
| Apr 01 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 11.29 | 28,689 | 323,899 | 151,489 | 122.8 K to 151.5 K (+23.36 %) |
| Mar 01 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 46.26 | 6,530 | 302,061 | 122,800 | 129.3 K to 122.8 K (-5.05 %) |
| Mar 01 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 45.56 | 11,794 | 537,303 | 129,330 | 141.1 K to 129.3 K (-8.36 %) |
| Feb 22 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 8,803 | 0 | 0 | |
| Feb 22 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 48.69 | 4,364 | 212,483 | 141,124 | 145.5 K to 141.1 K (-3.00 %) |
| Feb 22 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 8,803 | 0 | 145,488 | 136.7 K to 145.5 K (+6.44 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 7,883 | 0 | 15,766 | |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 8,134 | 0 | 24,399 | |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 49.84 | 2,725 | 135,814 | 133,186 | 135.9 K to 133.2 K (-2.00 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 7,883 | 0 | 135,911 | 128 K to 135.9 K (+6.16 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 50.60 | 2,906 | 147,044 | 128,028 | 130.9 K to 128 K (-2.22 %) |
| Feb 12 2021 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 8,134 | 0 | 130,934 | 122.8 K to 130.9 K (+6.62 %) |
| Dec 21 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 43.25 | 600 | 25,951 | 122,800 | 123.4 K to 122.8 K (-0.49 %) |
| Dec 21 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 42.54 | 11,400 | 484,967 | 123,400 | 134.8 K to 123.4 K (-8.46 %) |
| Nov 20 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 39.04 | 7,889 | 307,955 | 134,800 | 142.7 K to 134.8 K (-5.53 %) |
| Nov 20 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 38.24 | 4,111 | 157,221 | 142,689 | 146.8 K to 142.7 K (-2.80 %) |
| Oct 20 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 30.43 | 12,000 | 365,148 | 146,800 | 158.8 K to 146.8 K (-7.56 %) |
| Oct 20 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 30.43 | 12,000 | 365,148 | 146,800 | 158.8 K to 146.8 K (-7.56 %) |
| Sep 21 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 26.91 | 12,000 | 322,884 | 158,800 | 170.8 K to 158.8 K (-7.03 %) |
| Aug 20 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 28.30 | 12,000 | 339,564 | 170,800 | 182.8 K to 170.8 K (-6.56 %) |
| Jul 20 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 29.01 | 12,000 | 348,072 | 182,800 | 194.8 K to 182.8 K (-6.16 %) |
| May 22 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 7.14 | 18,613 | 132,897 | 0 | |
| May 22 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 7.14 | 18,613 | 132,897 | 194,800 | 176.2 K to 194.8 K (+10.56 %) |
| May 21 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 7.14 | 21,387 | 152,703 | 18,613 | |
| May 21 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Sell | S | 23.80 | 21,387 | 509,075 | 176,187 | 197.6 K to 176.2 K (-10.82 %) |
| May 21 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 7.14 | 21,387 | 152,703 | 197,574 | 176.2 K to 197.6 K (+12.14 %) |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 8,803 | 0 | 8,803 | |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 21.83 | 3,044 | 66,451 | 176,187 | 179.2 K to 176.2 K (-1.70 %) |
| Feb 24 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 8,803 | 0 | 179,231 | 170.4 K to 179.2 K (+5.17 %) |
| Feb 18 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 5,772 | 0 | 11,542 | |
| Feb 18 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 21.10 | 1,995 | 42,095 | 170,428 | 172.4 K to 170.4 K (-1.16 %) |
| Feb 18 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 5,772 | 0 | 172,423 | 166.7 K to 172.4 K (+3.46 %) |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 7,883 | 0 | 23,649 | |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 20.00 | 2,725 | 54,500 | 166,651 | 169.4 K to 166.7 K (-1.61 %) |
| Feb 13 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 7,883 | 0 | 169,376 | 161.5 K to 169.4 K (+4.88 %) |
| Feb 12 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | A | 0.00 | 32,533 | 0 | 32,533 | |
| Feb 12 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | A | 19.98 | 69,174 | 1,382,097 | 69,174 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 11,559 | 0 | 0 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 19.21 | 4,289 | 82,392 | 161,493 | 165.8 K to 161.5 K (-2.59 %) |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 11,559 | 0 | 165,782 | 154.2 K to 165.8 K (+7.49 %) |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Option Exercise | M | 0.00 | 11,559 | 0 | 0 | |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Payment of Exercise | F | 19.21 | 4,289 | 82,392 | 161,493 | 165.8 K to 161.5 K (-2.59 %) |
| Feb 04 2020 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | SVP, Chief Technica ... | Buy | M | 0.00 | 11,559 | 0 | 165,782 | 154.2 K to 165.8 K (+7.49 %) |
| May 11 2011 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | VP, Product Develop ... | Option Exercise | A | 0.00 | 19,000 | 0 | 19,000 | |
| Feb 04 2011 | GYHT | HALOZYME THERAPEUT ... | LaBarre Michael J. | VP, Product Develop ... | Option Exercise | A | 7.14 | 40,000 | 285,600 | 40,000 |
Page: 1